ALEXANDER V. MAYWEG,ANDREW THOMAS,DIDIER ROMBACH,EMANUELE GABELLIERI,HANS HILPERT,HARALD MAUSER,MARK ROGERS-EVANS,THOMAS WOLTERING,WOLFGANG GUBA,WOLFGANG WOSTL
申请号:
BR112013020019
公开号:
BR112013020019A2
申请日:
2012.03.15
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
The present invention relates to 1,4-Oxazepines of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease and type 2 diabetes.